Equity Market Research
Monday, 9 October 2017
This small-cap pharma laggard is a buy with 65% upside: Motilal Oswal https://goo.gl/wNNdBR
This small-cap pharma laggard is a buy with 65% upside: Motilal Oswal https://goo.gl/wNNdBR
https://goo.gl/wNNdBR
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment